Wellstat Therapeutics Corporation
http://www.wellstattherapeutics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Wellstat Therapeutics Corporation
Pediatric COVID-19 Vaccine Face-Off Looms As Bharat Biotech Heads For Approval
While Bharat Biotech is close to an accelerated approval of Covaxin in two to 18-year-olds, Zydus Cadila is yet to roll out its COVID-19 vaccine in India. As they head to a face-off in pediatric vaccines, the former faces manufacturing constraints and the latter hesitance over a first of its kind DNA vaccine. Experts speak to Scrip on which one stands a better chance of winning.
Focus On J&J, Pfizer COVID-19 Vaccine Pricing As India Permits Private Sales
Prices for J&J and Pfizer’s COVID-19 vaccines will be watched closely as India permits private sales. While demand is set to spike with age criteria for those eligible to receive the shots expanded, local manufacturers Serum Institute and Bharat Biotech are ramping up capacities with the government’s help.
A 'More Radical Idea': Set Expiration Dates For Priority Review Vouchers
Sanofi executive offers five-year voucher life-span as potential option for sustaining the resale market.
A Baker’s Dozen Of US FDA Efficacy Approvals Using Real World Evidence
Fresenius Kabi’s Omegaven is most recent of 13 approvals, including three with breakthrough therapy designations, where FDA has relied on real world evidence to make a regulatory decision about efficacy.
Company Information
- Industry
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Wellstat Group